Close Menu

The Next Big Thing

There was once a time that researchers had to be convinced that molecular population genetics was useful, says Mike the Mad Biologist. Once the field became popular, the "early adopters" who were regularly using PCR and clone-based sequences were "hot intellectual commodities" — that is until the field became overcrowded, and nearly every department already had a molecular population geneticist. A few years before that, Mike says, there was a similar phenomenon in marine biology with clonal invertebrate biologists. So which niche is next?

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.